Why the study?
HDL modulates endothelial nitric oxide synthase (eNOS) activity, but the effect of endothelial lipase (EL) on HDL-induced eNOS activation had not been investigated.
Does endothelial lipase-modified HDL improve eNOS activity and vasorelaxation in endothelial cells and mouse aortic rings?
Does endothelial lipase-modified HDL improve eNOS activity and vasorelaxation in endothelial cells and mouse aortic rings?
Endothelial lipase modification of HDL increases its capacity to activate eNOS and promote vasorelaxation by enriching the plasma membrane eNOS pool.
Suggests potential to enhance endothelial function via EL-modified HDL in models; leaves open translation to human vascular therapies.
Endothelial lipase (EL) changes structural and functional properties of high-density lipoprotein (HDL). HDL is a relevant modulator of endothelial nitric oxide synthase (eNOS) activity, but the effect of EL on HDL induced eNOS-activation has not yet been investigated. Here, we examined the impact of EL-modified HDL (EL-HDL) on eNOS activity, subcellular trafficking, and eNOS- dependent vasorelaxation. EL-HDL and empty virus (EV)-HDL as control were isolated from human serum incubated with EL-overexpressing or EV infected HepG2 cells. EL-HDL exhibited higher capacity to induce eNOS phosphorylation at Ser1177 and eNOS activity in EA.hy 926 cells, as well as eNOS-dependent vasorelaxation of mouse aortic rings compared to control HDL. As revealed by confocal and structured illumination-microscopy EL-HDL-driven induction of eNOS was accompanied by an increased eNOS-GFP targeting to the plasma membrane and a lower eNOS-GFP colocalization with Golgi and mitochondria. Widefield microscopy of filipin stained cells revealed that EL-HDL lowered cellular free cholesterol (FC) and as found by thin-layer chromatography increased cellular cholesterol ester (CE) content. Additionally, cholesterol efflux capacity, acyl-coenzyme A: cholesterol acyltransferase activity, and HDL particle uptake were comparable between EL-HDL and control HDL. In conclusion, EL increases eNOS activating capacity of HDL, a phenomenon accompanied by an enrichment of the plasma membrane eNOS pool, a decreased cell membrane FC and increased cellular CE content.
No takes yet. Share an insight, caveat, or question.
Radulović et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: